BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 8, 2019
View Archived Issues
New inhibitor blocks, degrades MYC
Read More
Study identifies metabolic path from stress to anxiety
Read More
Antisense oligonucleotides inhibit nonsense-mediated RNA decay in W1282X cystic fibrosis
Read More
AVEO Oncology and Biodesix initiate CyFi-2 study of ficlatuzumab plus high-dose cytarabine
Read More
EIP Pharma releases data from the REVERSE-SD study of neflamapimod
Read More
Mologen announces the initiation of phase IIa TITAN combination trial
Read More
Positive topline data from phase III VANISH-303 registration study of oral ibrexafungerp
Read More
Voclosporin DDI study demonstrates no clinically significant interaction with MMF
Read More
Discovery and preclinical characterization of a novel anti-CD178 antibody, FBP-002
Read More
Antisense therapy with antagomiR-23b shows promise for the treatment of DM1
Read More
Novel nonhuman primate model of induced colitis
Read More
Psioxus Therapeutics presents series of oncolytic viral compounds for cancer
Read More
Recombinant human thrombomodulin evaluated for ARDS with disseminated intravascular coagulation
Read More
Merck KGaA starts phase III study of L-praziquantel orodispersible in Schistosoma-infected children
Read More
Novel gene therapy for the treatment of Alzheimer's disease
Read More
AAV encoding NUsc1 rescues memory in Alzheimer's disease model
Read More
Supernus Pharmaceuticals provides data from phase III P301 study of SPN-810
Read More
Researchers divulge new compounds for malaria
Read More
Masitinib reduces severe asthma exacerbation rate in phase III study
Read More
Constellation Pharmaceuticals patents EZH2 inhibitors
Read More
Merck & Co. synthesizes new IDO1 inhibitors
Read More
The Medicines discloses new boronic acid-based antibacterials
Read More
C4 Therapeutics discovers new cereblon ligands for cancer
Read More
Targeting acquired immunity improves brain injury recovery
Read More
Affimed's IND for AFM-24 cleared for phase I/II study in EGFR-expressing cancers
Read More
AvantGen enters collaboration to use NK cell engager platform to generate anticancer therapeutics
Read More
Promising phase I data presented for the mutant-selective KRAS G12C inhibitor MRTX-849
Read More
